| 2019 | | 2018 Guidelines for the management of dyslipidemia | 김혜진 |
| 2023 | | Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study | 김혜진 |
| 2018 | | Blood adiponectin levels are not associated with risk of cardiovascular events in patients with type 2 diabetes | 김대중, 김혜진, 이관우, 전자영, 하경화, 한승진 |
| 2020 | | Body Fat Is Related to Sedentary Behavior and Light Physical Activity but Not to Moderate-Vigorous Physical Activity in Type 2 Diabetes Mellitus | 김혜진 |
| 2017 | | Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort: study protocol and results of the first 3 years of enrollment | 김대중, 하경화 |
| 2022 | | Cardiovascular disease in patients with type 2 diabetes | 김대중, 전자영 |
| 2017 | | Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data | 김대중, 하경화 |
| 2018 | | Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study | 김대중 |
| 2023 | | Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus | 김혜진 |
| 2021 | | Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data | 김대중 |
| 2019 | | Cohort Profile: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort in Korea | 김대중, 하경화 |
| 2018 | | Combined effects of diabetes and low household income on mortality: a 12-year follow-up study of 505 677 Korean adults | 김대중, 하경화 |
| 2018 | | Effect of Socioeconomic Status and Underlying Disease on the Association between Ambient Temperature and Ischemic Stroke | 하경화 |
| 2011 | | Effects of a cardiovascular risk reduction intervention with psychobehavioral strategies for Korean adults with type 2 diabetes and metabolic syndrome. | 김대중 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2013 | | Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in association with postsurgical metabolic changes. | 한승진 |
| 2023 | | Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients | 김대중, 김혜진, 박범희, 이관우, 전자영, 한승진 |
| 2015 | | Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. | 강대용, 김대중, 박광주, 박주헌, 박진선, 신승수, 신준한, 안영환, 양형모, 이규성, 임홍석, 정우영, 정윤정, 탁승제 |
| 2011 | | Intake of brown rice lees reduces waist circumference and improves metabolic parameters in type 2 diabetes. | 김대중, 김혜진, 이관우, 이민석, 한승진 |
| 2021 | | Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study | 김대중, 하경화 |
| 2023 | | Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study | 김대중 |
| 2006 | | Normative values of carotid artery intima-media thickness in healthy Korean adults and estimation of macrovascular diseases relative risk using this data in type 2 diabetes patients. | 김대중 |
| 2015 | | Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans. | 김대중 |
| 2015 | | PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. | 김대중 |
| 2006 | | Relationship between metabolic syndrome and familial history of hypertension/stroke, diabetes, and cardiovascular disease. | 이관우, 전기홍 |
| 2020 | | Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study | 김대중 |
| 2020 | | Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study | 김흥수, 박인휘, 신규태, 최용준 |
| 2021 | | Trends in the effects of pre-transplant diabetes on mortality and cardiovascular events after kidney transplantation | 박범희, 오창권, 전자영, 하경화, 한승진 |
| 2016 | | Trends in the Impact of Diabetes on the Development of Cardiovascular Diseases | 김대중, 하경화 |
